Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Intellia Therapeutics Inc Logo

ARKG Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Lock Icon
Date
Direction
Shares
Fund Weight
Fund
October 13, 2021BUY515590.0943%ARKG
October 8, 2021BUY1063950.1861%ARKG
August 17, 2021BUY425010.0774%ARKG
August 11, 2021BUY435990.0769%ARKG
December 9, 2020SELL527990.0506%ARKG
  • 1
  • 2
  • 5 / page

Key Statistics

🕵🏼Found In🏷Last Price
ARKKARKG$131.14
⚖️Weighting🧢Market Cap
3.06%$9.64b
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
10230.5
🏋️‍♀️Weight Rank Across All Funds🌏Country
15🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$36.172.26%
Description
Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creating enhanced engineered cells that can treat oncological and immunological diseases. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create new classes of therapeutic products.
Website
www.intelliatx.com